Stroup, T Scott <br/><br/>
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.  [electronic resource] 

 -  The American journal of psychiatry  Mar 2007 
 - 415-27 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-953X 
<br/><br/><label>Standard No.: </label>10.1176/ajp.2007.164.3.415  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--adverse effects<br/>Benzodiazepines--adverse effects<br/>Chronic Disease<br/>Dibenzothiazepines--adverse effects<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Olanzapine<br/>Patient Dropouts<br/>Perphenazine--administration & dosage<br/>Proportional Hazards Models<br/>Psychiatric Status Rating Scales<br/>Quetiapine Fumarate<br/>Risperidone--adverse effects<br/>Schizophrenia--diagnosis<br/>Schizophrenic Psychology<br/>Treatment Outcome